EcoDrugPlus

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSPTIG00000019258
Gene Symbol: CSF1R
2 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSPTIG00000021139
Gene Symbol: C1S
2 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSPTIG00000015109
Gene Symbol: C5
2 Cross references
208 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSPTIG00000007610
Gene Symbol: CRHR1
2 Cross references
240 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSPTIG00000019837
Gene Symbol: CDK1
2 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSPTIG00000018583
Gene Symbol: CDK2
2 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSPTIG00000010434
Gene Symbol: CDK4
1 Cross references
209 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPTIG00000012765
Gene Symbol: CDK5
2 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSPTIG00000010732
Gene Symbol: CDK6
1 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSPTIG00000017478
Gene Symbol: CDK7
2 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSPTIG00000004750
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPTIG00000008260
Gene Symbol: CYSLTR1
2 Cross references
177 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).